NEW YORK CITY — In a powerful demonstration of the intersection between public advocacy and scientific rigor,...
Patient Advocacy and Support
October, Breast Cancer Awareness Month, paints our world in shades of pink. From ubiquitous product promotions to...
TORONTO — A landmark national survey released by Breast Cancer Canada has unveiled a profound public consensus:...
Main Facts: A Quarter-Century of Impact in Cancer Surveillance Lori Swain, MS, stands as one of the...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
In the rapidly shifting landscape of modern oncology, the transition from traditional, generalized treatment protocols to highly...
The serene landscape of Arizona in 2024 was meant to be a sanctuary for Alyssa Butts—a place...
TORONTO — As the medical community and patient advocates observe Breast Cancer Awareness Month, Breast Cancer Canada...
NEW YORK – In the heart of Manhattan, where the relentless pace of commuter life usually dictates...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) medications have surged into...
